Search research articles
Contact Us
Filters
Showing results (21-30 of 62) with videos related to
Page
of 7
Sort By:
ANZ Journal of Surgery
|
September 19, 2017
Neoadjuvant systemic therapy for breast cancer: the Westmead experience
Annelise M Cocco, David Messer, Alexander Brown, et al.
Cancer
|
January 14, 2009
A phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanoma
Ahmad A Tarhini, Michael Millward, Paul Mainwaring, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 29, 2014
Acute Radiation Skin Toxicity Associated With BRAF Inhibitors
Trish Pulvirenti, Angela Hong, Arthur Clements, et al.
Implementation Science : IS
|
May 29, 2020
Clinicians' attitudes and perceived barriers and facilitators to cancer treatment clinical practice guideline adherence: a systematic review of qualitative and quantitative literature
Mia Bierbaum, Frances Rapport, Gaston Arnolda, et al.
Asia-Pacific Journal of Clinical Oncology
|
December 2, 2016
Optimizing combination dabrafenib and trametinib therapy in BRAF mutation-positive advanced melanoma patients: Guidelines from Australian melanoma medical oncologists
Victoria Atkinson, Georgina V Long, Alexander M Menzies, et al.
American Journal of Therapeutics
|
January 14, 2014
Treatment algorithms in stage IV melanoma
Enrique Espinosa, Jean-Jacques Grob, Reinhard Dummer, et al.
Investigational New Drugs
|
February 17, 2021
First-in-human, phase I/IIa study of CRLX301, a nanoparticle drug conjugate containing docetaxel, in patients with advanced or metastatic solid malignancies
Sarina A Piha-Paul, Kyaw Z Thein, Paul De Souza, et al.
Case Reports in Oncological Medicine
|
August 9, 2014
Symptomatic Histologically Proven Necrosis of Brain following Stereotactic Radiation and Ipilimumab in Six Lesions in Four Melanoma Patients
Stephanie Du Four, Angela Hong, Matthew Chan, et al.
Investigational New Drugs
|
October 6, 2006
A phase II study of bosentan, a dual endothelin receptor antagonist, as monotherapy in patients with stage IV metastatic melanoma
Richard Kefford, Jane McNeil Beith, Guy Arthur Van Hazel, et al.
Journal of Medical Genetics
|
October 7, 2018
Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline <i>CDKN2A</i> mutations
Hildur Helgadottir, Paola Ghiorzo, Remco van Doorn, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 62) with videos related to
Sort By:
Page
of 7
ANZ Journal of Surgery
|
September 19, 2017
Neoadjuvant systemic therapy for breast cancer: the Westmead experience
Annelise M Cocco, David Messer, Alexander Brown, et al.
Cancer
|
January 14, 2009
A phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanoma
Ahmad A Tarhini, Michael Millward, Paul Mainwaring, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 29, 2014
Acute Radiation Skin Toxicity Associated With BRAF Inhibitors
Trish Pulvirenti, Angela Hong, Arthur Clements, et al.
Implementation Science : IS
|
May 29, 2020
Clinicians' attitudes and perceived barriers and facilitators to cancer treatment clinical practice guideline adherence: a systematic review of qualitative and quantitative literature
Mia Bierbaum, Frances Rapport, Gaston Arnolda, et al.
Asia-Pacific Journal of Clinical Oncology
|
December 2, 2016
Optimizing combination dabrafenib and trametinib therapy in BRAF mutation-positive advanced melanoma patients: Guidelines from Australian melanoma medical oncologists
Victoria Atkinson, Georgina V Long, Alexander M Menzies, et al.
American Journal of Therapeutics
|
January 14, 2014
Treatment algorithms in stage IV melanoma
Enrique Espinosa, Jean-Jacques Grob, Reinhard Dummer, et al.
Investigational New Drugs
|
February 17, 2021
First-in-human, phase I/IIa study of CRLX301, a nanoparticle drug conjugate containing docetaxel, in patients with advanced or metastatic solid malignancies
Sarina A Piha-Paul, Kyaw Z Thein, Paul De Souza, et al.
Case Reports in Oncological Medicine
|
August 9, 2014
Symptomatic Histologically Proven Necrosis of Brain following Stereotactic Radiation and Ipilimumab in Six Lesions in Four Melanoma Patients
Stephanie Du Four, Angela Hong, Matthew Chan, et al.
Investigational New Drugs
|
October 6, 2006
A phase II study of bosentan, a dual endothelin receptor antagonist, as monotherapy in patients with stage IV metastatic melanoma
Richard Kefford, Jane McNeil Beith, Guy Arthur Van Hazel, et al.
Journal of Medical Genetics
|
October 7, 2018
Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline <i>CDKN2A</i> mutations
Hildur Helgadottir, Paola Ghiorzo, Remco van Doorn, et al.
Page
of 7